Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 676 - 700 of 1564 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ▼ ChEBI ID Exact Mass Formula
Gangliosides LMSP0601DM04
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262647 1951.076546 C91H162N4O40
Gangliosides LMSP0601DM03
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262646 1923.045246 C89H158N4O40
Gangliosides LMSP0601DM02
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262645 1895.013946 C87H154N4O40
Gangliosides LMSP0601DM01
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262644 1866.982646 C85H150N4O40
Gangliosides LMSP0601DL08
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • sialyl-Lea(d18:1/26:1(17Z))
44262643 1802.044122 C87H155N3O35
Gangliosides LMSP0601DL07
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • sialyl-Lea(d18:1/24:1(15Z))
44262642 1774.012822 C85H151N3O35
Gangliosides LMSP0601DL06
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • sialyl-Lea(d18:1/26:0)
44262641 1804.059772 C87H157N3O35
Gangliosides LMSP0601DL05
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • sialyl-Lea(d18:1/24:0)
44262640 1776.028472 C85H153N3O35
Gangliosides LMSP0601DL04
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • sialyl-Lea(d18:1/22:0)
44262639 1747.997172 C83H149N3O35
Gangliosides LMSP0601DL03
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • sialyl-Lea(d18:1/20:0)
44262638 1719.965872 C81H145N3O35
Gangliosides LMSP0601DL02
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • sialyl-Lea(d18:1/18:0)
44262637 1691.934572 C79H141N3O35
Gangliosides LMSP0601DL01
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • sialyl-Lea(d18:1/16:0)
44262636 1663.903272 C77H137N3O35
Gangliosides LMSP0601DK08
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • sialyl-lactotetraosylceramide(d18:1/26:1(17Z))
44262635 1655.986212 C81H145N3O31
Gangliosides LMSP0601DK07
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • sialyl-lactotetraosylceramide(d18:1/24:1(15Z))
44262634 1627.954912 C79H141N3O31
Gangliosides LMSP0601DK06
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • sialyl-lactotetraosylceramide(d18:1/26:0)
44262633 1658.001862 C81H147N3O31
Gangliosides LMSP0601DK05
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • sialyl-lactotetraosylceramide(d18:1/24:0)
44262632 1629.970562 C79H143N3O31
Gangliosides LMSP0601DK04
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • sialyl-lactotetraosylceramide(d18:1/22:0)
44262631 1601.939262 C77H139N3O31
Gangliosides LMSP0601DK03
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • sialyl-lactotetraosylceramide(d18:1/20:0)
44262630 1573.907962 C75H135N3O31
Gangliosides LMSP0601DK02
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • sialyl-lactotetraosylceramide(d18:1/18:0)
44262629 1545.876662 C73H131N3O31
Gangliosides LMSP0601DK01
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • sialyl-lactotetraosylceramide(d18:1/16:0)
44262628 1517.845362 C71H127N3O31
Gangliosides LMSP0601DI08
  • KDN GD1a 2(d18:1/26:1(17Z))
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262627 1865.028533 C88H156N2O39
Gangliosides LMSP0601DI07
  • KDN GD1a 2(d18:1/24:1(15Z))
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262626 1836.997233 C86H152N2O39
Gangliosides LMSP0601DI06
  • KDN GD1a 2(d18:1/26:0)
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262625 1867.044183 C88H158N2O39
Gangliosides LMSP0601DI05
  • KDN GD1a 2(d18:1/24:0)
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262624 1839.012883 C86H154N2O39
Gangliosides LMSP0601DI04
  • KDN GD1a 2(d18:1/22:0)
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262623 1810.981583 C84H150N2O39

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024